Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-023283
Filing Date
2022-02-14
Accepted
2022-02-14 17:38:24
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm226624-2_5seq1.html 5  
1 OWNERSHIP DOCUMENT tm226624-2_5seq1.xml 5 13194
  Complete submission text file 0001104659-22-023283.txt   14555
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Issuer) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 780 EAST MAIN STREET C/O BIOXCEL THERAPEUTICS, INC. BRANFORD CT 06405
Business Address
Mehta Vimal (Reporting) CIK: 0001733369 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-38410 | Film No.: 22635397